Positioning the ongoing company to raised meet the needs of the changing medical community.
We are very excited about the inclusion of the Caiman products into the Aesculap family of surgical instruments. This acquisition will widen the scope of our medical instrument portfolio and enhance Aesculap’s type of products to improve patient care, said Chuck DiNardo, President of Aesculap, Inc. This transaction will allow for improved distribution of the Caiman product line, said Roseanne Varner, Chief and President Executive Officer of Aragon, while providing our clients with the continued top quality service they attended to expect. .. Aesculap acquires possessions of Aragon Surgical Today that it has acquired the resources of Aragon Surgical Aesculap announced, Inc.Related StoriesLiposomal sizing and the Coulter principle: an interview with Professor Melvin E. KlegermanExpanded make use of for IntelliCap with further CE Mark for aspiration of liquids The Panel and shareholders of Allos backed the proposed merger with AMAG predicated on the strategic rationale, anticipated operating synergies and potential for future development of the core brands. With the termination of the merger contract, we will remain focused on growing U.S. Sales of FOLOTYN for relapsed or refractory PTCL, in addition to pursuing future label growth opportunities in T-cell lymphoma and regulatory authorization in the EU, which might occur in early 2012, commented Paul L.